Funder
Tsinghua medical student scholarship
Pennsylvania Department of Health
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Nelson, H. D. et al. In Screening for Breast Cancer: A Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews (2016).
2. Alluri, P. G., Speers, C. & Chinnaiyan, A. M. Estrogen receptor mutations and their role in breast cancer progression. Breast Cancer Res 16, 494,
https://doi.org/10.1186/s13058-014-0494-7
(2014).
3. Jeselsohn, R., Buchwalter, G., De Angelis, C., Brown, M. & Schiff, R. ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol 12, 573–583,
https://doi.org/10.1038/nrclinonc.2015.117
(2015).
4. Reinert, T., Saad, E. D., Barrios, C. H. & Bines, J. Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer. Front Oncol 7, 26,
https://doi.org/10.3389/fonc.2017.00026
(2017).
5. Robinson, D. R. et al. Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet 45, 1446–1451,
https://doi.org/10.1038/ng.2823
(2013).